References
- Sarhan OM, El-Ghoneimi AA, Helmy TE, et al. Posterior urethral valves: multivariate analysis of factors affecting the final renal outcome. J Urol 2011;185:2491–5
- Drozdz D, Drozdz M, Gretz N, et al. Progression to end-stage renal disease in children with posterior urethral valves. Pediatr Nephrol 1998;12:630–6
- Hennus PM, van der Heijden GJ, Bosch JL, et al. A systematic review on renal and bladder dysfunction after endoscopic treatment of infravesical obstruction in boys. PLoS One 2012;7:e44663
- Denes ED, Barthold JS, Gonzalee R. Early prognostic value of serum creatinine levels in children with posterior urethral valves. J Urol 1997;157:1441–3
- Deshpande AV, Alsaywid BS, Smith GH. Setting the speed limit: a pilot study of the rate of serum creatinine decrease after endoscopic valve ablation in neonates. J Urol 2011;185:2497–501
- Lopez Pereira P, Espinosa L, Martinez Urrutina MJ, et al. Posterior urethral valves: prognostic factors. BJU Int 2003;91:687–90
- Nickavar A, Otoukesh H, Sotoudeh K. Validation of initial serum creatinine as a predictive factor for development of end stage renal disease in posterior urethral valves. Indian J Pediatr 2008;75:695–7
- Pohl M, Mentzel HJ, Vogt S, et al. Risk factors for renal insufficiency in children with urethral valves. Pediatr Nephrol 2012;27:443–50
- Sarhan O, El-Dahsanhan K, Sarhan M. Prognostic value of serum creatinine levels in children with posterior urethral valves treated by primary valve ablation. J Pediatr Urol 2010;6:11–14
- Allegaert K, Kuppens M, Mekahli D, et al. Creatinine reference values in ELBW infants: impact of quantification by Jaffe or enzymatic method. J Matern Fetal Neonatal Med 2012;25:1678–81
- Cuzzolin L, Fanos V, Pinna B, et al. Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 2006;21:931–8
- Boer DP, de Rijke YB, Hop WC, et al. Reference values for serum creatinine in children younger than 1 year of age. Pediatr Nephrol 2010;25:2107–13
- Gajewski K. Cardiology. In: Tschudy M, Arcara K, eds. The Harriet lane handbook. 19th ed. Philadelphia: Elsevier Mosby; 2012: 160–3
- Lebowitz RL, Olbing H, Parkkulaien KV, et al. International system of radiographic grading of vesicoureteric reflux. International Reflux Study in Children. Pediatr Radiol 1985;15:105–9
- Allegaert K, Keltemans J, Hendrickx S, Smits A. (2001). Available from: http://trabajos.cin2011.uninet.edu/162/allegaert.pdf. [last accessed 19 Oct 2013]
- Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate GFR. In: Stockman J, ed. Yearbook of pediatrics. Philadelphia: Elsevier Mosby; 2011:193–4
- Hogg RJ, Furth S, Lemley KV, et al; National Kidney Foundation's Kidney Disease Outcomes Quality Initiative. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 2003;111:1416–21
- Ansari MS, Gulia A, Srivastava A, Kapoor R. Risk factors for progression to end stage renal disease in children with posterior urethral valves. J Pediatr Urol 2010;6:261–4
- Ducan L, Heathcote J, Djurdjev O, Levin A. Screening for renal disease using serum creatinine: who are we missing? Nephrol Dial Transplant 2001;16:1042–6
- Mandelia A, Bajpai M, Agarwala S, et al. The role of urinary TGF-β1, TNF-α, IL-6 and microalbuminuria for monitoring therapy in posterior urethral valves. Pediatr Nephrol 2013;28:1991–2001
- Klein J, Lacroix C, Caubet C, et al. Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with Posterior Urethral Valves (PUV). Sci Transl Med 2013;5:198ra106
- Morris RK, Malin GL, Quinlan-Jones E, et al; For the percutaneous vesicoamniotic shunting in Lower Urinary Tract Obstruction (PLUTO) Collaborative Group. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial. Lancet 2013;385:1496–506